Culture enriched molecular profiling of the cystic fibrosis airway microbiome
about
The microbiome of the lungBacterial-viral load and the immune response in stable and exacerbated COPD: significance and therapeutic prospectsThe Challenge and Potential of Metagenomics in the ClinicVaccines for Pseudomonas aeruginosa: a long and winding roadThe cystic fibrosis lower airways microbial metagenomeEtiologic diagnosis of lower respiratory tract bacterial infections using sputum samples and quantitative loop-mediated isothermal amplificationThe role of the bacterial microbiome in lung diseaseThe effects of inhaled aztreonam on the cystic fibrosis lung microbiome.Bronchial microbiome of severe COPD patients colonised by Pseudomonas aeruginosaBacteria isolated from lung modulate asthma susceptibility in mice.Significance of the microbiome in chronic obstructive pulmonary disease.The metabolic footprint of the airway bacterial community in cystic fibrosis.Intestinal dysbiosis and bacterial enteroinvasion in a murine model of Hirschsprung's disease.Host cytokine responses distinguish invasive from airway isolates of the Streptococcus milleri/anginosis group.Aspirated bile: a major host trigger modulating respiratory pathogen colonisation in cystic fibrosis patients.The "most wanted" taxa from the human microbiome for whole genome sequencingSerial analysis of the gut and respiratory microbiome in cystic fibrosis in infancy: interaction between intestinal and respiratory tracts and impact of nutritional exposuresThe adult cystic fibrosis airway microbiota is stable over time and infection type, and highly resilient to antibiotic treatment of exacerbationsClinical identification of bacteria in human chronic wound infections: culturing vs. 16S ribosomal DNA sequencing.Phenotypic heterogeneity of Pseudomonas aeruginosa populations in a cystic fibrosis patient.The microbial community of the cystic fibrosis airway is disrupted in early life.Rapid 16S rRNA next-generation sequencing of polymicrobial clinical samples for diagnosis of complex bacterial infections.Quantifying the impact of storage procedures for faecal bacteriotherapy in the critically endangered New Zealand parrot, the kakapo (Strigops habroptilus).The microbiome of the upper airways: focus on chronic rhinosinusitis.Comparison of microbiomes from different niches of upper and lower airways in children and adolescents with cystic fibrosis.Human pharyngeal microbiome may play a protective role in respiratory tract infections.Culture and molecular-based profiles show shifts in bacterial communities of the upper respiratory tract that occur with age.Novel microbiome-based therapeutics for chronic rhinosinusitis.Prevalence and impact of Streptococcus pneumoniae in adult cystic fibrosis patients: a retrospective chart review and capsular serotyping study.Cohort Study of Airway Mycobiome in Adult Cystic Fibrosis Patients: Differences in Community Structure between Fungi and Bacteria Reveal Predominance of Transient Fungal Elements.The Role of Short-Chain Fatty Acids, Produced by Anaerobic Bacteria, in the Cystic Fibrosis AirwayCystic fibrosis lung microbiome: opportunities to reconsider management of airway infection.The development and application of a molecular community profiling strategy to identify polymicrobial bacterial DNA in the whole blood of septic patientsAssessment of the Microbial Constituents of the Home Environment of Individuals with Cystic Fibrosis (CF) and Their Association with Lower Airways Infections.The human microbiome and its potential importance to pediatrics.A multidimensional approach to the management of severe asthma: Inflammometry, molecular microbiology and bronchial thermoplastyPyrosequencing Unveils Cystic Fibrosis Lung Microbiome Differences Associated with a Severe Lung Function DeclineCapturing the diversity of the human gut microbiota through culture-enriched molecular profilingMicrobiome profiling of drinking water in relation to incidence of inflammatory bowel disease.A comparison of intestinal microbiota in a population of low-risk infants exposed and not exposed to intrapartum antibiotics: The Baby & Microbiota of the Intestine cohort study protocol
P2860
Q24602074-2B8665F7-3F17-4E6D-8EDB-23B4D5876330Q26752882-23F1C700-6D82-416B-BF21-63FB1F62BFACQ26766414-55BDE98A-56DF-4FFE-9A87-2353D6920FD5Q26852817-7C545AC4-3D3C-485B-81EA-57651C3F01CAQ28596642-AE631661-395E-467C-BC6C-A1C91768CBD4Q28728441-C2E4CAEB-031F-48A6-AF43-074F40FA4C0AQ33554623-03246356-E7AA-4485-BE4D-1E4BDD1BD03DQ33644835-DA7B3287-492A-4601-BB79-4B4F0AC87F81Q33701145-192E0932-8F5E-410E-A088-95891F895DF8Q33707521-1EA6C32E-7CCC-4CCD-A474-1DAABCBD289AQ33817613-A6D0DCAD-AF8E-4D30-83F4-11D01FFD8E1BQ33861701-CE01324D-A7DF-4C59-90FB-3E6B03CF8F20Q34007118-6E23129A-A648-4F12-8474-6A16533CF94CQ34246158-1DCD187E-EC9B-47CB-8A76-BE7D49C5A990Q34277932-90FAB98D-18EF-4CD2-AFCD-00B2F78E0F6BQ34358290-B6382837-4F6C-421C-8A7D-A083BC043485Q34388328-11122B46-C481-4CD6-86BA-108B1A55541CQ34437958-BDF6F543-088E-40A7-BEBB-01961F33A8CEQ34487105-A3094094-F7BC-4BC5-9F9A-A643B1065951Q34661901-C3063A2B-505D-4EC2-A0BA-0CE67F558529Q34744222-152DEA4E-961F-42FC-B8A4-9277E6D30457Q34755870-14BF735F-94C2-4612-BCDB-2BA3878084E2Q34982476-974991AE-7F30-4BD4-9469-519423A8D5C4Q35012395-83E40D58-B244-4E27-B868-5885D46C7FB4Q35023645-8C4B86C7-E472-44E2-A420-6546B58E3AA9Q35192938-EAE366BC-F540-4119-B53B-302BBEBF878AQ35536029-3096F3DF-EA36-44E1-A535-C6D2901AB581Q35578935-6F233549-954A-4303-B793-C0B7879FFD86Q35616635-80869BE7-18F6-4964-9BF5-CCB5A4025BDFQ35681203-50B2ED05-EADF-4F39-A46C-B0495CA22082Q35743588-EFB7D3CB-53FB-47B7-8506-41D286A8B2A5Q35763672-2BEA7A30-A4F4-47B8-8FAB-8F2B25B0BAB2Q35810781-A139E8F8-42F8-4FD9-9F37-5A88E86C083EQ35918209-8A5116D9-1A11-4950-9126-C82C9B17AE60Q35923573-780B7601-F845-48AE-AD7B-EA7B00E8F56AQ35934380-C9500B5B-A364-4DCF-A74D-1CFE4195DCB5Q36063996-0737E33C-FA77-474C-8769-AB239768C623Q36065363-467E25A8-2565-4F97-BC87-81B3E435B0EFQ36078564-E301CE97-A35F-4C87-9401-39C1C40FC533Q36189178-78CA7F3D-0498-4F42-B936-DAEC05E703C7
P2860
Culture enriched molecular profiling of the cystic fibrosis airway microbiome
description
2011 nî lūn-bûn
@nan
2011 թուականին հրատարակուած գիտական յօդուած
@hyw
2011 թվականին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
Culture enriched molecular profiling of the cystic fibrosis airway microbiome
@ast
Culture enriched molecular profiling of the cystic fibrosis airway microbiome
@en
Culture enriched molecular profiling of the cystic fibrosis airway microbiome
@nl
type
label
Culture enriched molecular profiling of the cystic fibrosis airway microbiome
@ast
Culture enriched molecular profiling of the cystic fibrosis airway microbiome
@en
Culture enriched molecular profiling of the cystic fibrosis airway microbiome
@nl
prefLabel
Culture enriched molecular profiling of the cystic fibrosis airway microbiome
@ast
Culture enriched molecular profiling of the cystic fibrosis airway microbiome
@en
Culture enriched molecular profiling of the cystic fibrosis airway microbiome
@nl
P2093
P2860
P3181
P1433
P1476
Culture enriched molecular profiling of the cystic fibrosis airway microbiome
@en
P2093
Christina S Eshaghurshan
Christopher D Sibley
Harvey R Rabin
Margot E Grinwis
Michael D Parkins
Michael G Surette
Monica M Faria
Tyler R Field
P2860
P304
P3181
P356
10.1371/JOURNAL.PONE.0022702
P407
P50
P577
2011-01-01T00:00:00Z